Evidence map›Paper›PMID 37243508›Full record

ArticleEuropean stroke journal2023

Decline of thrombolysis rates before endovascular therapy in patients with acute anterior circulation large vessel occlusion ischemic stroke: A multicenter analysis from the German Stroke Registry.

Ludwig Schlemm, Eberhard Siebert, Justus F Kleine, Christoph Riegler, Felix J Bode, Martina Petersens, Eckhard Schlemm, Fee Keil, Steffen Tiedt, Georg Bohner and 1 more

Abstract readMulticenter Study
In one paragraph

Article in European stroke journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ludwig SchlemmInstitute of Neuroradiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-4165-2366
Eberhard SiebertInstitute of Neuroradiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Justus F KleineInstitute of Neuroradiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christoph RieglerKlinik und Hochschulambulanz für Neurologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Felix J BodeDepartment of Neurology, Universitätsklinikum Bonn, Bonn, Germany.
Martina PetersensDepartment of Neurology, Klinikum Osnabrück, Osnabruck, Germany.
Eckhard SchlemmKlinik und Poliklinik Für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Fee KeilInstitute for Neuroradiology, University Hospital, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Steffen TiedtInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.
Georg BohnerInstitute of Neuroradiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christian H NolteDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-5577-1775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn recent years, the role of intravenous thrombolysis (IVT) before endovascular stroke treatment (EVT) has been discussed intensively. Whether the discussion was accompanied by changing rates of bridging IVT is unknown.

methodsData were extracted from the prospectively maintained German Stroke Registry, including patients treated with EVT at one of 28 stroke centers in Germany between 2016 and 2021. Primary outcome parameters were the rate of bridging IVT (a) in the entire registry cohort and (b) in patients without formal contraindications to IVT (i.e. recent oral anticoagulants, time window ⩾4.5 h, extensive early ischemic changes) adjusted for demographic and clinical confounders.

results10,162 patients (52.8% women, median age 77 years, median National Institutes of Health Stroke Scale score 14) were analyzed. In the entire cohort, the rate of bridging IVT decreased from 63.8% in 2016 to 43.6% in 2021 (average absolute annual decrease 3.1%, 95% CI 2.4%-3.8%), while the proportion of patients with at least one formal contraindication increased by only 1.2% annually (95% CI 0.6%-1.9%). Among 5460 patients without record of formal contraindications, the rate of bridging IVT decreased from 75.5% in 2016 to 63.2% in 2021 and was significantly associated with admission date in a multivariable model (average absolute annual decrease 1.4%, 95% CI 0.6%-2.2%). Clinical factors associated with lower odds of bridging IVT included diabetes mellitus, carotid-T-occlusion, dual antiplatelet therapy, and direct admission to a thrombectomy center.

conclusionWe observed a substantial decline in bridging IVT rates independent of demographic confounders and not explained by an increase in contraindications. This observation deserves further exploration in independent populations.

Indexed as

Arterial Occlusive DiseasesCarotid Artery DiseasesEndovascular ProceduresIschemic StrokeStrokeThrombosisAgedFemaleHumansMaleRegistriesThrombolytic TherapyUnited Statesacute reperfusion treatmentclinical decision makingendovascular treatmentIschemic strokelarge vessel occlusionthrombectomythrombolysis

Identifiers

PMID37243508
PMCPMC10472953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.